Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment

University of Colorado, Denver32 enrolled

Overview

The purpose of this study is to assess the acceptability, appropriateness, and feasibility of a educational video series for patients going through breast cancer treatment.

This is a prospective, mixed methods pilot study to evaluate the acceptability, appropriateness, and feasibility of a novel educational video series for patients going through breast cancer treatment. The video series addresses topics such as what to expect from breast surgery, how to prepare for breast surgery, treatment effects of breast cancer therapies, and mitigation and communication strategies for navigating breast cancer treatment.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Breast Cancer Female Sexual Dysfunction

Interventions

Educational video seriesOTHER

The intervention is a web-based educational video series that was developed using a patient-centered approach that discusses breast cancer treatment, sexual health side effects, and provides treatment and mitigation strategies for these side effects.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Stage I-III invasive breast cancer within one month of initial multi-disciplinary clinic visit or surgical consultation * Ability to complete survey material independently * Able to read and speak English * Willingness to comply with study material and procedures Exclusion Criteria: * Age \< 18 years old * Stage 0 or IV breast cancer * Non-breast cancer diagnoses * History of anti-hormonal therapy, chemotherapy, or radiotherapy not related to breast cancer * Prior breast cancer diagnosis

Locations (1)

University of Colorado Health

Aurora, Colorado, United States

Outcomes

Primary Outcomes

Acceptability of the educational video series after six-months of access and use by breast cancer patients as measured by AIM instrument.

The Acceptability of Intervention Measure (AIM) is a validated instrument used to measure the acceptability of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater acceptability).

Time frame: 6 months

Appropriateness of the educational video series after six-months of access and use by breast cancer patients as measured by IAM instrument.

The Intervention Appropriateness Measure (IAM) is a validated instrument used to measure the appropriateness of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater appropriateness).

Time frame: 6 months

Determine the sustainability of the educational video series after six-months of access and use by breast cancer patients as measured by the FIM instrument.

The Feasibility of Intervention Measure (FIM) is a validated instrument used to measure the feasibility, or sustainability, of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater feasibility).

Time frame: 6 months

Secondary Outcomes

Change from baseline in sexual health and function at six-months, as measured by the PROMIS Sexual Function v2 Brief Profile (Female)

The Patient-Reported Outcomes Measurement Information System (PROMIS) Sexual Function v2 Brief Profile (Female) is a well-validated tool in oncology patients to assess sexual health. Calibrated subdomain scores are expressed as T-scores (mean=50, standard deviation=10). A T-score 50 corresponds to the mean response among cancer survivors used for previous item testing. Higher scores indicate better outcomes within the domain. We will assess the change at 6 months from baseline.

Time frame: Baseline, 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.